Nozhat Z - Search Results

1

CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review.

Zarkesh M, Arab N, Abooshahab R, Heydarzadeh S, Sheikholeslami S, Nozhat Z, Salehi Jahromi M, Fanaei SA, Hedayati M. Zarkesh M, et al. Among authors: nozhat z. Cancer Cell Int. 2022 Oct 11;22(1):310. doi: 10.1186/s12935-022-02720-w. Cancer Cell Int. 2022. PMID: 36221112 Free PMC article.

2

PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.

Nozhat Z, Hedayati M. Nozhat Z, et al. Mol Diagn Ther. 2016 Feb;20(1):13-26. doi: 10.1007/s40291-015-0175-y. Mol Diagn Ther. 2016. PMID: 26597586 Review.

3

Thyroid Cancer Epidemic: A Peril or an Alarm?

Nozhat Z, Hedayati M, Azizi F. Nozhat Z, et al. Int J Endocrinol Metab. 2015 Oct 10;13(4):e28491. doi: 10.5812/ijem.28491. eCollection 2015 Oct. Int J Endocrinol Metab. 2015. PMID: 26633981 Free PMC article. No abstract available.

4

Medullary thyroid carcinoma: a review on ethical considerations in treatment of children.

Nozhat Z, Hedayati M. Nozhat Z, et al. J Pediatr Endocrinol Metab. 2016 Jun 1;29(6):633-9. doi: 10.1515/jpem-2015-0309. J Pediatr Endocrinol Metab. 2016. PMID: 26974132 Review.

5

Can the Serum Level of Myostatin be Considered as an Informative Factor for Cachexia Prevention in Patients with Medullary Thyroid Cancer?

Hedayati M, Nozhat Z, Hannani M. Hedayati M, et al. Among authors: nozhat z. Asian Pac J Cancer Prev. 2016;17(S3):119-23. doi: 10.7314/apjcp.2016.17.s3.119. Asian Pac J Cancer Prev. 2016. PMID: 27165248 Free article.

6

Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines.

Nozhat Z, Mohammadi-Yeganeh S, Azizi F, Zarkesh M, Hedayati M. Nozhat Z, et al. Daru. 2018 Dec;26(2):93-103. doi: 10.1007/s40199-018-0208-2. Epub 2018 Sep 21. Daru. 2018. PMID: 30242671 Free PMC article.

7

BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.

Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Nozhat Z, Fanaei SA, Hedayati M, Azizi F. Zarkesh M, et al. Among authors: nozhat z. Life Sci. 2019 Apr 15;223:166-173. doi: 10.1016/j.lfs.2019.03.034. Epub 2019 Mar 16. Life Sci. 2019. PMID: 30890403

8

Different Methods for Cell Viability and Proliferation Assay: Essential Tools in Pharmaceutical Studies.

Nozhat Z, Khalaji MS, Hedayati M, Kia SK. Nozhat Z, et al. Anticancer Agents Med Chem. 2022;22(4):703-712. doi: 10.2174/1871520621999201230202614. Anticancer Agents Med Chem. 2022. PMID: 33390140

9

Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.

Nozhat Z, Zarkesh M, Baldini E, Mohammadi-Yeganeh S, Azizi F, Hedayati M. Nozhat Z, et al. Anticancer Agents Med Chem. 2022;22(4):713-720. doi: 10.2174/1871520621666210118093532. Anticancer Agents Med Chem. 2022. PMID: 33461474

10

Application of Bacterial Nanocellulose in Cancer Drug Delivery: A Review.

Shahriari-Khalaji M, Zarkesh M, Nozhat Z. Shahriari-Khalaji M, et al. Among authors: nozhat z. Curr Pharm Des. 2021;27(34):3656-3665. doi: 10.2174/1381612827666210412150445. Curr Pharm Des. 2021. PMID: 33845723 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters